Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Summit Therapeutics Inc. | Director | Stock Option (right to buy) | 200K | $139K | $1.32 | Oct 11, 2024 | Direct |
Pulse Biosciences, Inc. | Director | Stock Option (right to buy) | 8.03K | May 20, 2021 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
SMMT | Summit Therapeutics Inc. | Oct 11, 2024 | 1 | $0 | 4 | Oct 15, 2024 | Director |
SMMT | Summit Therapeutics Inc. | Jan 2, 2024 | 2 | $93K | 4 | Jan 4, 2024 | Director |
SMMT | Summit Therapeutics Inc. | Jan 3, 2023 | 2 | $74.1K | 4 | Jan 5, 2023 | Director |
SMMT | Summit Therapeutics Inc. | Jan 3, 2022 | 2 | $66.1K | 4 | Jan 5, 2022 | Director |
SMMT | Summit Therapeutics Inc. | Oct 7, 2021 | 2 | $0 | 4 | Oct 12, 2021 | Director |
SMMT | Summit Therapeutics Inc. | Oct 7, 2021 | 0 | $0 | 3 | Oct 12, 2021 | Director |
PLSE | Pulse Biosciences, Inc. | May 20, 2021 | 2 | $0 | 4 | May 21, 2021 | Director |